Parallel Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Parallel Advisors's TNDM Position: Q2 2026 in Review
Parallel Advisors reduced its Tandem Diabetes Care (TNDM) stake by 75% in Q2 2026, selling an estimated $3.49K and leaving 65 shares worth $981. The position accounts for ﹤0.01% of the portfolio, ranked #3697.
Parallel Advisors first reported a position in TNDM in Q4 2021 and has held it in 19 quarters since. The position peaked at $52.7K in Q2 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Parallel Advisors held 65 shares of Tandem Diabetes Care worth $981 as of Q2 2026.
- Parallel Advisors sold 200 Tandem Diabetes Care shares in Q2 2026, an estimated $3.49K.
- Tandem Diabetes Care made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3697 holding.
- Parallel Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 19 quarters since.
- Parallel Advisors's Tandem Diabetes Care position peaked at $52.7K in Q2 2024.
- 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.